Text of Compulsory Licenses
January 29, 2007.
Decree of Department of Disease Control, Ministry of Public Health, Regarding
Exploitagion of Patent on Drugs & Medical Supplies by the Government
on Combination Drug Between Lopinavir & Ritonavir.
January 25, 2007.
Ministry of Public Health Announcement Regarding Exploitation of Patents on Drugs and Medical Supplies for Clopidogrel.
November 29, 2006.
Announcement of the Department of Disease Control, Ministry of Public Health, Thailand on the
Public use of patent for Pharmaceutical Products. For more information on the
dispute of there Efavirenz compulsory license, click
here.
Knowedge Ecology International Documents
May 3, 2007.
Abbott recently sought compulsory license in US patent dispute.
April 30, 2007.
KEI Statement on USTR 301 list reference to Thailand.
April 26, 2007.
Compulsory Licenses on Patents.
April 25, 2007. James Love in the Huffington Post.
What do Democrats.com have against poor people in Thailand getting affordable medicines?
April 2, 2007. James Love in the Huffington Post.
Senator Lieberman and Four Others Rap Thailand Compulsory Licenses on Non-AIDS Drugs.
March 8, 2007. James Love.
Recent examples of the use of compulsory licenses on patents.
January 25, 2007. James Love. "Knowledge Ecology International (KEI) Statement on Thailand Compulsory licenses". Knowledge Ecology International (KEI).
December 28, 2006. James Love in the Huffington Post. Article on Huffington Post on U.S. response to the Thai compulsory license.
December 24, 2007. James Love. Some recent examples of the use of compulsory licenses.
December 12, 2006. James Love.
Letter asking USTR not to interfere with the Thai government decision to issue a government-use license on patents covering the AIDS drug efavirenz.
July 23, 2001. Background document by Susannah Markandya.
Timeline of Trade Disputes involving Thailand and access to medicine.
Government Documents
Thai Government
February 2007. Thai Ministry of Public Health and National Health Security Office White Paper Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand.
Western Governments
April 30, 2007. USTR.
Section on Thailand from the 301 Report.
March 26, 2007. French Ministry of Foreign Affairs.
Recours aux licences obligatoires du gouvernement thaïlandais pour deux
anti-rétroviraux contre le VIH/SIDA (unofficial English translation.)
March 20, 2007. Sens. Lieberman, Carper, Menendez, Feinstein and Lautenburg.
Letter to USTR opposing Thai compulsory licenses.
March 15, 2007. Letter to USTR from 12 Members of Congress
opposing Thai compulsory licenses.
February 8, 2007. Ambassador Susan Schwab, United States Trade Representative.
Response to James Love of KEI's letter in regards to Thailand's legal issuance of a compulsory license on a patented medicine.
January 17, 2006. Ambassador Susan Schwab, United States Trade Representative
response to the 22 member Congressional letter, opposing interference with Thailand's legal efforts to ensure affordable access to the AIDS drug efavirenz.
January 10, 2006. Letter from 22 members of Congress to Ambassador Susan Schwab, United States Trade Representative, opposing interference with Thailand's legal efforts to ensure affordable access to the AIDS drug efavirenz.
.pdf format
NGO Documents
Joint NGO Documents
May 10, 2007. Joint Statement by 15 NGOs.
Thai civil society supports the health ministers of Thailand and Brazil and calls
on pharmaceutical companies and lobbyists to stop abusing their power.
April 27, 2007. American Medical Student Association and the Student Global AIDS Campaign.
Hundreds Rally in Chicago to Confront Abbott's Blackmail of Thai Patients; Abbott CEO Dismisses Thai AIDS Activists at Annual Shareholders Meeting.
April 26, 2007. Joint statement on th Day of Action by Korean NGOs.
Stop Bargaining Over Life!
April 24, 2007. Joint press release from the Student Global AIDS Campaign, Health GAP,
American Medical Students Association Essential Action, Global AIDS Alliance, Universities
Allied for Essential Medicines, Stop HIV/AIDS in India Initiative, Center for Health &
Gender Equity, ACT UP Philadelphia, ACT UP Austin, ACT UP NY.
Abbott Labs Must Stop Attacks on Thai People With AIDS - Protests Planned 26th & 27th
in DC, Chicago, Austin, Worcester, and Around the World.
April 23, 2007. Knowledge Ecoloby International, Probram on Information Justice and
Intellectual Property, and Health GAP.
World's "Premiere" Law Firm Goes to Bat for Abbott:
Specious Arguments on Thailand's Compulsory Licenses.
April 11, 2006. Médecins Sans Frontières and Oxfam.
Discount Price Offered for Kaletra/Aluvia -
What Abbott must do next.
Médecins Sans Frontières
March 25, 2007. Transcript of press teleconference.
Thailand, Abbott, and the Second-Line Aids Crisis.
March 23, 2007. Press Release.
Abbott should reconsider its unacceptable decision to not sell new medicines in Thailand
March 16, 2007. Buddhima Lokuge.
Statement delivered at Congressional breifing on Thailand's compulsory licenses.
March 15, 2007. Press Release.
MSF Denounces Abbott’s Move to Withhold Medicines From People in Thailand.
March 14, 2007. Briefing Note.
Abbott's New and Improved Kaletra: Only in the US... But What About the Rest of the World?.
December 19, 2006. Nicolas de Torrente, Executive Director of Medecins Sans
Frontieres-USA, and Paul Cawthorn, Head of Mission, MSF-Thailand.
Letter to US Secretary of State Condoleezza Rice and US Trade Representative Susan Schwab.
Health GAP
May 9, 2007. Brook Baker, Health GAP.
US Action Plan for Thailand Comes Straight from Pharma.
April 25, 2007. Response to op-ed by Abbott's lawyers in the Bangkok Post (see below).
April 21, 2007.
Abbott's New Blackmail with a Smile.
April 12, 2007.
Abbott's Blackmail Against Thailand Continues
March 15, 2007.
A New Low in the Pharma Drug Wars - Abbott Withdraws Seven Medicines in
Thailand
March 13, 2007.
Standing Up To Abbott's Decision to Withhold Registration and
Marketing of Life-Saving Medicines - A New Variant of
Pharmaceutical Apartheid
February 1, 2007.
PhRMA's Seven Deadly Lies about Thai Compulsory Licenses.
Project on Information Justice and Intellectual Property
PIJIP's Page on the Thailand Compulsory Licensing Dispute
April 26, 2007. Report by Sean Flynn.
Thailand's Lawful Compulsory Licensing and Abbott's Anticompetive Response.
April 26, 2007. Press release.
PIJIP Releases Report on Thai Compulsory Licenses and Abbott’s Subsequent Refusal to Register New Medicines.
Interfaith Center on Corporate Responsibility
April 26, 2007. Report by Lisa Sachs.
Human Rights Challenges Facing Abbott Laboratories:
Risks and recommendations.
April 26, 2007. Press release.
"Right to Health" Creates Substantial Human Rights Risks for Abbott Laboratories, Report Finds.
April 16, 2007. Press release.
Institutional Investors Respond to Aluvia Announcement by Abbott Labs,
May 2, 2007. ACT-UP Paris.
Abbott laboratory is threatening Act Up-Paris: An unbearable
judicial pressure is put on HIV patients.
May 9, 2007. Essential Action.
Embarrassing: Ken Adelman and USA for Innovation's Latest Untruths.
April 30, 2007. Essential Action.
USTR Action Against Thailand: Outrageous, Cynical, Shameful.
April 26, 2007. Rainbow-Push Coalition.
Rev. Jackson Asks Abbott to Make AIDS Medicine Available in Thailand.
April 27, 2007. Student Global AIDS Campaign.
SGACers Join Activists Around The World in Protest of Abbott Labs;
Demand Universal Access to AIDS Drugs.
April 26, 2007. Universities Allied for Essential Medicines.
Letter to the Wisconsin Alumni Research Foundation, which owns one of the patents covering Kaletra.
April 26, 2007. ACT UP New York.
AIDS Activists Confront Magic Johnson at Abbott Forum -
Former NBA Star Voices Support for Activist Demands for Access for Poor Countries.
April 26, 2007. AIDS Healthcare Foundation.
AIDS Healthcare Foundation Says CalPERS to Question Abbott on Thailand Drug Blacklist.
April 26, 2007. Stop AIDS Campaign.
Abbott Laboratories Makes Students Sick.
April 18, 2007. European AIDS Treatment Group and the AIDS Treatment Activists Coalition.
Letter to Abbott CEO Miles White.
April 16, 2007. Joint letter by Abbott Shareholders.
Institutional investors respond to Aluvia announcement by Abbott Labs/
April 13, 2007. Oxfam.
Abbott Pharmaceuticals in Thailand: Fact Sheet.
April 11, 2007. Johannes van de Weerd and Dr. Tido von Schoen-Angerer.
Letter Leaders on the G4 Delegation to
WTO Talks in India.
April 10, 2007. Joint statement from Health GAP, the Student Global
AIDS Campaign, the American Medical Student Association, and
Essential Action. NGO Response to
Abbott’s announced $1000 price for Aluvia in Low- and Lower-Middle
Income Countries
April 3, 2007. Roger Bate for the American Enterprise Institute.
Thailand and the Drug Patent Wars.
March 26, 2007. American Medical Students Association.
US Medical Students Stand in Solidarity with Thais in Response
to Abbott Laboratories' Withholding Essential Medications.
March 22, 2007. Christian Brothers Investment Services.
CBIS and ICCR Urge Abbott Labs to Keep HIV/AIDS Drug on the Shelf in Thailand
March 15, 2007. Student Global AIDS Campaign.
Students Condemn Abbott’s Refusal to Sell AIDS Drugs to Thai People.
March 13, 2007. AIDS Healthcare Foundation.
AIDS Healthcare Foundation 'Horrified' as Abbott Blacklists Thailand From New Drugs.
February 9, 2007. Delhi Network of Positive People, Indian Network for People
Living with HIV/AIDS, Affordable Medicines and Treatment Campaign, Community
Health Cell.
Letter to the World Health Organization and UNAIDS on Thai Compulsory Licenses.
February 2, 2007. AIDS Healthcare Foundation.
New WHO Chief Fails To Stand Up for People Living with AIDS.
January 31, 2007. Robert Weissman for Essential Action.
Clarifications on Thai Compulsory Licensing.
December 22, 2006. Brook Baker for Health GAP.
U.S. Pursuit of TRIPS-plus Intellectual Property Rights and its
Opposition to Thailand's Lawful Compulsory License for Merck's
Efavirenz Undermines its own Global AIDS Initiative, Threatening a
Fivefold Increase in the Costs of Medicines.
December 21, 2006. Letter to Condoleezza Rice, Secretary of State, and Ambassador Susan Schwab, United States Trade Representative, regarding pressures on Thailand for issuing a compulsory license for AIDS drug efavirenz. .pdf format and .html format.
December 18, 2007. Sean Flynn for American University, WCL Program on Information Justice
and Intellectual Property.
Analysis of Thai Law on Government Use Licenses.
Business Group and Industry Documents
USA for Innovation
USA for Innovation is registered as a non-profit organization,
though it is run a lawyer for a PR firm which represents Abbott, PhRMA,
a number of other pharmaceutical companies, and former Thai Prime
Minister Thaskin.
May 9, 2007. Ken Adelman.
Letter to Members of Congress.
April 30, 2007.
USA For Innovation Applauds Action From USTR to Support American Innovation.
April 27, 2007. Op-ed in the Washington Times.
Troubles from Thailand.
April 25, 2007.
USA for Innovation Ad Campaign Highlights Thailand's Theft of American Assets
- Over 35,000 letters sent to President Bush and U.S. Policymakers.
April 23, 2007.
Letter to Bush Administration Cabinet Members.
April 23, 2007.
USA for Innovation Calls on Administration Officials to Confront
Thailand's Theft of US Property.
May 14, 21007. PhRMA press release.
Compulsory Licensing Trend Dangerous.
April 23, 2007. Op-ed by Peerapan Tungsuwan and William McKay in the Bangkok Post.
The authors work for Baker & McKenzie, which represents Abbott.
Compulsory drug licences violate world trade treaty.
April 10, 2007. Abbott press release.
Abbott Agrees with WHO Director-General to Expand
Access to Kaletra/Aluvia (lopinavir/ritonavir).
April, 2007. Cipla press release.
Generic heat stable lopinavir/ritonavir launched in India.
March 20, 2007. U.S. Chamber of Commerce.
Chamber Study Exposes Investor Concerns In Thailand.
International Organizations
February 7, 2007. Dr. Margaret Chan, Director General of the World Health Organization.
Letter to Dr. Mongkoi Na Songkhla, Thailand's Minister of Health.
October 19, 2005. World Trade Organization FAQ.
Compulsory licensing of pharmaceuticals and TRIPS.
This document explains the actual rules concerning the issuance of
TRIP-complian compulsory licenses. For instance, it addresses the
common misperception that compulsory licenses are only supposed to
be used in "emergencies."
News Stories
May 30, 2007. Pharma Times.
Thai government drugmaker all set to sue US lobby group.
May 29, 2007. Andy Mukherjee for Bloomberg News.
Drug innovation and the public good.
May 28, 2007. Chalathip Thirasoonthrakul for Reuters.
Thailand to override more patented drugs-minister.
May 28, 2007. Agence France Presse.
Thailand eyes bigger generic drug programme.
May 27, 2007. Erica Fry for the Bangkok Post.
Spinning a New Image.
May 25, 2007. Inside US Trade.
Thailand Minister Open to Talks, Considering More Compulsory Licenses.
May 23, 2007. Ian Swanson for the Hill.
PhRMA takes aim at Thailand for production of generics, hints that it will push for sanctions.
May 23, 2007. Reuters.
Thailand Fails to Win Over U.S. on Drug Patents.
May 22, 2007. Apiradee Treerutkuarkul.
Interview with U.S. Ambassador Ralph Boyce.
May 22, 2007. Darren Schuettler for Reuters.
Thai AIDS patients suffer as drug squabble drags on.
May 17, 2007. Marwaan Macan-Markar for the Asia Times.
Holding Big Pharma's feet to the fire.
May 16, 2007. Kaiser News Network.
Thailand Will Not Issue Compulsory Licenses for Patented Drugs if Pharmaceutical
Companies Match Generic Prices, Health Minister Says.
May 16, 2007. Songphol Sukchan, Director of Press Division, Department of Information.
Letter to the Editor of the Wall Street Journal.
Thailand's Compulsory Drug Licensing.
May 15, 2007. Reuters.
Thai drug patent overrides depend on price cuts.
May 14, 2007. Shawn Zeller for the Congressional Quarterly Weekly.
The Shadowy Drug Lobby That Has Thailand in Its Sites
May 11, 2007. Jon Cohen for Science Magazine.
Brazil, Thailand Override Big Pharma Patents.
May 11, 2007. Robert Weissman, Essential Action.
Response to Op-Ed by Ashley Wills in the Bangkok Post.
May 11, 2007. Op-ed by former Assistant USTR Ashley Wills in the Bangkok Post.
Putting US-Thai relations on track.
May 10, 2007. Interview with Dr. Tido von Schoen-Angerer, Executive Director of
the MSF Acess to Essential Medicines Campaign on Newsweek.com.
A Step Forward?
May 10, 2007. The Nation.
Clinton backs Thailand, as HIV drug deal signed.
May 10, 2007. Chicago Tribune editorial.
Abbott in Thailand.
May 9, 2007. Associated Press.
U.S. ex-President Clinton backs Thai move to break patents on AIDS drugs.
May 9, 2007. David Batty for the Guardian.
Clinton backs violation of Aids drug patents.
May 9, 2007. Pennapa Hongthong for the Nation.
US action plan must be opposed, groups tell government.
May 9, 2007. Daniel Ten Kate for the Asia Sentinel.
US-Thailand Dispute over Compulsory Licenses for AIDS Drugs.
May 7, 2007. Ed Silverman for Pharmalot.
Thailand: No More Broken Patents, For Now.
May 3, 2007. Apriadee Treeturkuarkul for the Bangkok Post.
Health vs economic interests.
May 3, 2007. The Nation.
Outrage grows at US trade pressure - HIV groups to march on embassy;
lobbyist linked to Thaksin PR firm.
May 2, 2007. Woranuj Maneerungsee and Apriadee Treeturkuarkul for the Bangkok Post.
Thailand on priority watch list - US move ridiculed by cheap drug advocates.
May 1, 2007. Associated Press.
Thailand to talk with U.S. about drug patents after being targeted for copyright violations.
May 1, 2007. Wall Street Journal Editorial.
Abbott's Bad Precedent.
News stories on the compulsory licensing dispute from January-April 2007.
